| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
|
Iguchi, Toyotaka
|
|
|
44 |
11 |
p. 1209-1214
|
article
|
| 2 |
Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015
|
Ersbøll, Annette Kjær
|
|
|
44 |
11 |
p. 1231-1242
|
article
|
| 3 |
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
|
Clinton, Joseph William
|
|
|
44 |
11 |
p. 1125-1149
|
article
|
| 4 |
Identifying Actionability as a Key Factor for the Adoption of ‘Intelligent’ Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach
|
Gavriilidis, George I.
|
|
|
44 |
11 |
p. 1165-1178
|
article
|
| 5 |
Inconsistent Safety Outcome Reporting in Randomized Clinical Trials of COVID-19 Vaccines Complicates Informed Medical Decisions
|
Blais, Joseph E.
|
|
|
44 |
11 |
p. 1121-1123
|
article
|
| 6 |
Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
|
Jessurun, Naomi T.
|
|
|
44 |
11 |
p. 1179-1191
|
article
|
| 7 |
Surveillance of Antidepressant Safety (SADS): Active Signal Detection of Serious Medical Events Following SSRI and SNRI Initiation Using Big Healthcare Data
|
Aakjær, Mia
|
|
|
44 |
11 |
p. 1215-1230
|
article
|
| 8 |
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
|
Bahri, Priya
|
|
|
44 |
11 |
p. 1193-1208
|
article
|
| 9 |
Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database
|
Moll, Keran
|
|
|
44 |
11 |
p. 1151-1164
|
article
|
Journal description